Jazz Pharmaceuticals plc buy Morgan Stanley
Start price
12.12.24
/
50%
€120.35
Target price
12.12.25
€167.02
Performance (%)
-6.94%
Price
20:02
€112.00
Summary
This prediction is currently active. With a performance of -6.94%, the BUY prediction by Morgan_Stanley is trending in the wrong direction. This prediction currently runs until 12.12.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 1.817% | 1.817% |
iShares Core DAX® | -0.940% | 2.343% |
iShares Nasdaq 100 | -0.726% | 1.863% |
iShares Nikkei 225® | -0.767% | 4.952% |
iShares S&P 500 | -0.345% | 2.613% |
Comments by Morgan_Stanley for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $175.00 price target on the stock, up previously from $140.00.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Morgan_Stanley for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€92.16
06.08.25
06.08.25
€140.03
06.08.26
06.08.26
21.53%
20:02
20:02
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€99.04
22.07.25
22.07.25
€141.14
22.07.26
22.07.26
13.09%
20:02
20:02
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€90.20
07.05.25
07.05.25
€146.33
07.05.26
07.05.26
24.17%
20:02
20:02
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€128.00
07.03.25
07.03.25
€168.73
07.03.26
07.03.26
-12.50%
20:02
20:02